Avanos Medical, Inc.
AVNS
$11.36
-$0.07-0.61%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4,163.16% | -557.44% | -574.87% | 130.37% | 131.67% |
| Total Depreciation and Amortization | 23.98% | 27.03% | 29.63% | 24.05% | -29.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7,390.77% | 511.70% | 535.29% | -86.63% | -91.65% |
| Change in Net Operating Assets | 341.33% | 251.09% | 190.67% | 53.64% | 48.01% |
| Cash from Operations | 84.09% | 330.77% | 210.80% | 3.93% | 16.89% |
| Capital Expenditure | -60.38% | -45.71% | -28.06% | -46.51% | 12.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 16.00% | -10.53% |
| Divestitures | -97.64% | -100.00% | -97.64% | -- | -- |
| Other Investing Activities | -980.95% | -- | -- | -- | -- |
| Cash from Investing | -273.14% | -246.61% | -227.31% | 195.02% | 220.40% |
| Total Debt Issued | -100.00% | -100.00% | -- | -- | -- |
| Total Debt Repaid | 36.01% | 36.83% | 55.22% | -174.94% | -145.41% |
| Issuance of Common Stock | 100.00% | 100.00% | 83.33% | 57.14% | -66.67% |
| Repurchase of Common Stock | 83.16% | 67.40% | -26.73% | -365.85% | -25.83% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 72.95% | 72.95% | 67.52% | -- | -- |
| Cash from Financing | -2.71% | -6.46% | 47.88% | -9,642.86% | -26.42% |
| Foreign Exchange rate Adjustments | 2,400.00% | -266.67% | -327.78% | -57.50% | -110.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -118.27% | 206.53% | 150.00% | -82.83% | 142.11% |